Assessment of the inflammatory process by endomyocardial biopsy in patients with dilated cardiomyopathy based on pathological and immunohistochemical methods

Kardiologia Polska

Volumn 64, Issue 5, 2006, Pages 479-487

  Prochorec Sobieszek, Monika ^a   Bilińska, Zofia T ^b   Grzybowski, Jacek ^b   Mazurkiewicz, Łukasz ^b   Skwarek, Mirosław ^b   Walczak, Ewa ^a   Michalak, Ewa ^b   Cedro, Krzysztof ^b   Chmielak, Zbigniew ^b   Dȩbski, Artur ^b   Demkow, Marcin ^b   Witkowski, Adam ^b   Wagner, Teresa ^a   Ruzyłło, Witold ^b  

^a INSTITUTE OF RHEUMATOLOGY   (Poland)

^b INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Adhesion molecules; Dilated cardiomyopathy; Immunohistochemistry; Inflammatory cardiomyopathy; Myocarditis

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA D ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MYOCARDITIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; SCORING SYSTEM; T LYMPHOCYTE;

EID: 33747231226     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Noutsias M, Pauschinger M, Schultheiss H-P, et al. Advances in the immunohistological diagnosis of inflammatory cardiomyopathy. Eur Heart J Suppl 2002; 4 (Suppl. I): I54-I62.
2. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation 2001; 104: 1076-82.
3. Pauschinger M, Bowles NE, Fuentes-Garcia FJ, et al. Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 1999; 99: 1348-54.
4. Aretz HT. Myocarditis: the Dallas criteria. Hum Pathol 1987; 18: 619-24.
5. Noutsias M, Pauschinger M, Poller WC, et al. Current insights into the pathogenesis, diagnosis and therapy of inflammatory cardiomyopathy. Heart Fail Monit 2003; 3: 127-35.
6. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996; 93: 841-2
7. Mason JW, O'Connell JB, Herskowitz A, et al.A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995; 333: 269-75.
8. Kuhl U, Noutsias M, Seeberg B, Schultheiss HP. Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart 1996; 75: 295-300.
9. Shanes JG, Ghali J, Billingham ME, et al. Interobserver variability in the pathologic interpretation of endomyocardial biopsy results. Circulation 1987; 75: 401-5.
10. Noutsias M, Seeberg B, Schultheiss HP, et al. Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. Circulation 1999; 99: 2124-31.
11. Wojnicz R, Nowalany-Kozielska E, Wodniecki J, et al. Immunohistological diagnosis of myocarditis. Potential role of sarcolemmal induction of the MHC and ICAM-1 in the detection of autoimmune mediated myocyte injury. Eur Heart J 1998; 19: 1564-72.
12. Kolbeck PC, Steenbergen C, Wolfe JA, et al. The correlation of mononuclear cell phenotype in endomyocardial biopsies with clinical history and cardiac dysfunction. Am J Clin Pathol 1989; 91: 37-44.
13. Noutsias M, Pauschinger M, Schultheiss H, et al. Phenotypic characterization of infiltrates in dilated cardiomyopathy - diagnostic significance of T-lymphocytes and macrophages in inflammatory cardiomyopathy. Med Sci Monit 2002; 8: CR478-87.
14. Bevilacqua MP, Nelson RM, Mannori G, et al. Endothelial-leukocyte adhesion molecules in human disease. Annu Rev Med 1994; 45: 361-78.
15. Devaux B, Scholz D, Hirche A, et al. Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. Eur Heart J 1997; 18: 470-9.
16. Herskowitz A, Ahmed-Ansari A, Neumann DA, et al. Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: a nonhistologic marker of myocarditis. J Am Coll Cardiol 1990; 15: 624-32.
17. Kuhl U, Noutsias M, Seeberg B, et al. Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart 1996; 75: 295-300.
18. Noutsias M, Pauschinger M, Ostermann K, et al. Digital image analysis system for the quantification of infiltrates and cell adhesion molecules in inflammatory cardiomyopathy. Med Sci Monit 2002; 8 (5): MT59-71.
19. Smith SC, Allen PM. Expression of myosin-class II major histocompatibility complexes in the normal myocardium occurs before induction of autoimmune myocarditis. Proc Natl Acad Sci USA 1992; 89: 9131-5.
20. Ansari AA, Wang YC, Danner DJ, et al. Abnormal expression of histocompatibility and mitochondrial antigens by cardiac tissue from patients with myocarditis and dilated cardiomyopathy. Am J Pathol 1991; 139: 337-54.
21. Toyozaki T, Saito T, Takano H, et al. Expression of intercellular adhesion molecule-1 on cardiac myocytes for myocarditis before and during immunosuppressive therapy. Am J Cardiol 1993; 72: 441-4.
22. Node K, Fujita M, Kitakaze M, et al. Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy. Circulation 2003 Aug; 108: 839-43.
23. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 2001; 104: 39-45.